{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"10.3","upperLimit":"66.7","value":"38.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"}],"units":"Participants"}],"description":"Cumulative Incidence of Acute GVHD Grades II-IV at day 100","dispersionType":"95% Confidence Interval","groups":[{"description":"Parathyroid hormone after double umbilical cord blood transplant.","id":"OG000","title":"Parathyroid Hormone (Teriparatide)"}],"paramType":"NUMBER","populationDescription":"13 patients were transplanted","reportingStatus":"POSTED","timeFrame":"Measured at Day 100","title":"Cumulative Incidence of Acute GVHD Grades II-IV at Day 100","type":"SECONDARY","unitOfMeasure":"percentage of participants"}